Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Media Resources
2022
HAI and Partners Launch SHARP Project
HAI Statement on Tentative Agreement on TRIPS and COVID-19
Statement to EB150: Global Strategy & Plan of Action
Statement to EB150: Pandemic Preparedness and Response
2021
Statement on Pandemic Prevention, Preparedness and Response
Spanish Research Institute Licence with C-TAP
Letter to the President of the European Council: European Council Meeting 20-21 October and TRIPS Waiver
Oproep aan Nederlandse regering: toon politieke daadkracht tijdens topconferenties en promoot eerlijke toegang tot Covid-19 vaccins
New study estimates over nine million people living with type 1 diabetes
Analogue Insulin on WHO Model List of Essential Medicines
MEPs can deliver strong message to Commission on TRIPS waiver
WHO Members States must not miss opportunity to improve lives of over 460 million people with diabetes
Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines
HAI Statement on the Oslo Medicines Initiative
2020
Health Action International Statement on the European Commission Pharmaceutical Strategy
HAI Statement to the 73rd WHA on public health, innovation and IP
HAI Statement to the WHO Executive Board – COVID-19
HAI Statement on Improving Access to Insulin
HAI Statement to the 70th Session of the WHO Regional Committee for Europe
COVID-19: Future of Pharmaceuticals Webinar
Medical Technologies for COVID-19 Developed with Public Money Must be Recognised as Global Public Goods
HAI during COVID-19
Statement on the Results of EP Plenary on COVID-19 Response
Guarantee transparency, affordability and availability of EU funded therapies for COVID-19, demand MEPs
CJEU ruling is victory that resonates for all in favour of greater transparency
2019